DUBLIN--(BUSINESS WIRE)--The "Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics in US$ Million.
The report profiles 27 companies including many key and niche players such as:
- Alcobra Ltd. (Israel)
- Amarantus Bioscience Holdings, Inc. (US)
- Amedra Pharmaceuticals LLC (US)
- Curemark, LLC. (US)
- Eli Lilly and Company (US)
- Intellipharmaceutics International, Inc. (US)
- Janssen Global Services, LLC (US)
- Mallinckrodt PLC (Ireland)
- Mylan N.V. (The Netherlands)
- Neos Therapeutics, Inc. (US)
- Neurovance, Inc. (US)
- Noven Pharmaceuticals, Inc. (US)
- Pfizer Inc. (US)
- Shire plc (Ireland)
- Supernus Pharmaceuticals, Inc. (US)
- Tris Pharma, Inc. (US)
Key Topics Covered
1. MARKET OVERVIEW
- ADHD Therapeutics: A Primer
- ADHD Therapeutics Market Outlook
- Factors Driving ADHD Therapeutics Market
- Changes in Insurance Coverage
- Addition of Formal Guidelines
- Low Diagnosis Threshold
- Advancements in Field of Medicine
- Unmet Needs
- Launch of Pipeline Drugs
- Factors Inhibiting ADHD Therapeutics Market
- Side Effects Related to Use of Stimulants to Treat ADHD
- Under-diagnosis of ADHD Condition
- Reduced Availability of Non-Stimulants in Certain Geographies
- Competitive Landscape
- Major ADHD Medications Available in the Market
- ADHD Medications Approved by FDA
-
Patent Validity for Major ADHD Drugs
2. NOTEWORTHY TRENDS IN ADHD THERAPEUTICS MARKET
- Biological Psychiatry Gaining Ground
- Social Media Drives Heightened Awareness
- Stimulants Dominate the Market but Non-Stimulants Inching Their Way to Popularity
- Robust Growth in Pediatric ADHD Therapeutic Market to Propel Overall Market
-
Strategic Alliances
3. DEVELOPMENTAL PIPELINE OF ADHD DRUGS
4. ADHD - AN INSIGHT
5. CLINICAL TRIALS
6. PRODUCTS INNOVATIONS/INTRODUCTIONS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 27 (including Divisions/Subsidiaries 28)
- The United States (17)
- Canada (2)
- Japan (2)
-
Europe (5)
- The United Kingdom (1)
- Rest of Europe (4)
- Middle East (2)
For more information about this report visit https://www.researchandmarkets.com/research/hm335k/attention_deficit?w=4
